Belite Bio, Inc (BLTE) Stock Forecast
Data as of Aug 5, 2026Healthcare · Current price $157.40 (+1.69%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
BLTE vs Sector & Market
| Metric | BLTE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 8 | 8 | 18 |
| Target Upside | +32.9% | +16316.1% | +17.1% |
| P/E Ratio | -68.59 | 3.39 | 36.31 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-03-31 | $16M | $16M | $16M | 1 |
| 2027-06-30 | $32M | $32M | $32M | 1 |
| 2027-09-30 | $47M | $47M | $47M | 1 |
| 2027-12-31 | $63M | $63M | $63M | 1 |
| 2028-03-31 | $86M | $86M | $86M | 1 |
| 2028-06-30 | $90M | $90M | $90M | 1 |
| 2028-09-30 | $98M | $98M | $98M | 1 |
| 2028-12-31 | $101M | $101M | $101M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-03-31 | $-0.41 | $-0.41 | $-0.41 | 1 |
| 2027-06-30 | $-0.13 | $-0.13 | $-0.13 | 1 |
| 2027-09-30 | $0.09 | $0.09 | $0.09 | 1 |
| 2027-12-31 | $0.36 | $0.36 | $0.36 | 1 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 2 |
| 2028-06-30 | $0.00 | $0.00 | $0.00 | 2 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 2 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 2 |
Frequently Asked Questions
What is the analyst consensus for BLTE?
The consensus among 8 analysts covering Belite Bio, Inc (BLTE) is Buy with an average price target of $208.00.
What is the highest price target for BLTE?
The highest analyst price target for BLTE is $217.00.
What is the lowest price target for BLTE?
The lowest analyst price target for BLTE is $191.00.
How many analysts cover BLTE?
8 analysts have issued ratings for Belite Bio, Inc in the past 12 months.
Is BLTE a buy or sell right now?
Based on 8 analyst ratings, BLTE has a consensus rating of Buy (2.00/5) with a +32.9% upside to the consensus target of $208.00.
What are the earnings estimates for BLTE?
Analysts estimate BLTE will report EPS of $-0.41 for the period ending 2027-03-31, with revenue estimated at $16M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.